Difference between revisions of "Part:BBa K2686002"
(→Self Assembly) |
(→Self Assembly) |
||
Line 21: | Line 21: | ||
The sequence was tested inside a a pet14 vector backbone inside an operon with a T7 promoter and a T7 terminator. | The sequence was tested inside a a pet14 vector backbone inside an operon with a T7 promoter and a T7 terminator. | ||
− | === | + | ===Assembly=== |
The self assembly of the encapsulin 60-mer was first examined using SDS PAGE, where a high band is expected to form due to the high molecular weight and size of the 1.3 MDalton complex. | The self assembly of the encapsulin 60-mer was first examined using SDS PAGE, where a high band is expected to form due to the high molecular weight and size of the 1.3 MDalton complex. | ||
Line 28: | Line 28: | ||
[[File:Encapsulins SDS.png|thumb|center|upright=3|SDS PAGE of the different encapsulin proteins expressed by iGEM EPFL 2018. | [[File:Encapsulins SDS.png|thumb|center|upright=3|SDS PAGE of the different encapsulin proteins expressed by iGEM EPFL 2018. | ||
Before (B) heat purification, the pellet after heat purification (P) and the supernatant after heat purification (S). | Before (B) heat purification, the pellet after heat purification (P) and the supernatant after heat purification (S). | ||
− | From left to right: '''1-3''' Negative control (cell-free PURE expression without DNA), '''4-6''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) showing bands for the encapsulin multimer high on the gel lanes as well as the monomer around 31kDa, '''7''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where bands are not easily discernible, '''8''' Ladder, '''9''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where the monomer band is visible at 31kDa, '''10-12''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) where the bands for the 60-mer and monomer can be identified, '''13-15''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where the bands can easily be discerned for both the monomer and 60-mer (note how the 60-mer band is more visible in the supernatant after heat purification | + | From left to right: '''1-3''' Negative control (cell-free PURE expression without DNA), '''4-6''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) showing bands for the encapsulin multimer high on the gel lanes as well as the monomer around 31kDa, '''7''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where bands are not easily discernible, '''8''' Ladder, '''9''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where the monomer band is visible at 31kDa, '''10-12''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) where the bands for the 60-mer and monomer can be identified, '''13-15''' HexaHis-OVA Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686000]]) where the bands can easily be discerned for both the monomer and 60-mer (note how the 60-mer band is more visible in the supernatant after heat purification)]] |
− | + | [[File:SDS LysBodipy.tiff|thumb|center|upright=3|SDS PAGE of encapsulins expressed in cell free PURE system with Lysine-BODIPY fluorescent tRNA's. The two different sets of lanes correspond to different heat denaturation temperatures (70C and 100C for 15 minutes). From left to right: '''N''' Negative control (cell-free PURE expression without DNA and no purification), '''L''' Positive control with DNA coding for Luciferase (37kDa), '''H''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) showing bands for the encapsulin multimer high on the gel lanes as well as the monomer around 31kDa, '''R''' Encapsulin ([[parts.igem.org/Part:BBa_K2686001|BBa_K2686001]]) without HexaHis linker, '''N''' Negative control (cell-free PURE expression without DNA and 100C denaturation), '''Ladder''', '''L''' Positive control with DNA coding for Luciferase (37kDa), '''H''' HexaHis Encapsulin ([[parts.igem.org/Part:BBa_K2686002|BBa_K2686002]]) showing bands for the encapsulin multimer high on the gel lanes as well as the monomer around 31kDa, '''R''' Encapsulin ([[parts.igem.org/Part:BBa_K2686001|BBa_K2686001]]) without HexaHis linker, '''N''' Negative control (cell-free PURE expression without DNA and 70C denaturation)]] | |
===References=== | ===References=== | ||
Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801. | Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801. |
Revision as of 09:36, 15 October 2018
Encapsulin protein with HexaHistidine insert
This is a BioBrick containing the sequence for Thermotoga maritima encapsulin, a bacterial protein nanocompartment which self assembles to form a 60-mer.
Usage and Biology
The part can be used to deliver cargo, both on the outer surface of the nanoparticle by fusing a peptide in between the 139/140 Amino Acids as well as the protein's C terminus. Cargo proteins can also be loaded inside the nano-cage using a tag binding to Encapsulin's interior surface. The protein is modified with an additonal amino acid sequence (GGGGGGHHHHHHGGGGG) between positions 43/44 granting it better stability and high heat resistance (Moon et al., 2014).
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 77
Illegal BglII site found at 492 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 426
Illegal SapI.rc site found at 457
Results
The sequence was tested inside a a pet14 vector backbone inside an operon with a T7 promoter and a T7 terminator.
Assembly
The self assembly of the encapsulin 60-mer was first examined using SDS PAGE, where a high band is expected to form due to the high molecular weight and size of the 1.3 MDalton complex. Multiple gels were made, some containing the denatured cell free reaction mixture, others containing the same but after a variety of purification procedures.
References
Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801.